Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
7
pubmed:dateCreated
2002-7-9
pubmed:abstractText
Basiliximab is a chimeric human/mouse monoclonal antibody directed against the alpha chain of the IL-2 receptor, CD25, which has been reported as successfully reducing rejection in adult renal transplant recipients. Reported clinical experience of basiliximab in paediatric renal transplantation is limited.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jul
pubmed:issn
0931-0509
pubmed:author
pubmed:issnType
Print
pubmed:volume
17
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1304-9
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:12105256-Antibodies, Monoclonal, pubmed-meshheading:12105256-Antilymphocyte Serum, pubmed-meshheading:12105256-Azathioprine, pubmed-meshheading:12105256-Child, pubmed-meshheading:12105256-Cyclosporine, pubmed-meshheading:12105256-Drug Therapy, Combination, pubmed-meshheading:12105256-Female, pubmed-meshheading:12105256-Follow-Up Studies, pubmed-meshheading:12105256-Graft Rejection, pubmed-meshheading:12105256-Graft Survival, pubmed-meshheading:12105256-Humans, pubmed-meshheading:12105256-Immunosuppressive Agents, pubmed-meshheading:12105256-Kidney Transplantation, pubmed-meshheading:12105256-Male, pubmed-meshheading:12105256-Postoperative Complications, pubmed-meshheading:12105256-Prednisolone, pubmed-meshheading:12105256-Recombinant Fusion Proteins, pubmed-meshheading:12105256-Time Factors, pubmed-meshheading:12105256-Transplantation, Homologous, pubmed-meshheading:12105256-Treatment Outcome
pubmed:year
2002
pubmed:articleTitle
Improved efficacy of basiliximab over antilymphocyte globulin induction therapy in paediatric renal transplantation.
pubmed:affiliation
Department of Paediatric Nephrology, Guy's Hospital, London, UK. godfrey.clark@kcl.ac.uk
pubmed:publicationType
Journal Article, Clinical Trial, Comparative Study, Controlled Clinical Trial